Production & Manufacturing

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs...

There is no shred of doubt that every stage of the pharmaceutical supply chain happens to be critical if the life-saving drugs are to make it to the market and patients who need them, all on time. It is well...

Pharmaceutical manufacturers face a twofold challenge. They not only have to produce vital medicines faster and more efficiently. They must also reduce energy and media consumption as well as costs. The example of pure steam generation shows that sometimes...

The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support the High-Quality Development of Innovative Drugs". The policy, which was formally unveiled to the...

The pharmaceutical sector stands at the crossroads of innovation and is indeed driven by global healthcare demands, advancements within technology, and immediate calls for sustainable practices. Outsourced pharmaceutical manufacturing, which is led by contract development and manufacturing organizations (CDMOs),...

It is well to be noted that the pharmaceutical sector has for long been characterized by its intricate, global supply chains designed in order to optimize production, decrease costs, and make sure that there is a timely delivery of...

In the very rapidly evolving pharmaceutical spectrum, the safeguarding of injectable biologics happens to be of utmost significance. These delicate products often need strict controls as well as protection from environmental factors that could compromise their efficacy. In the...